P
ProQR Therapeutics N.V. (PRQR)
NCM – Real Time Price. Currency in USD
1.53
-0.04 (-2.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.56
+0.03 (2.22%)
After-hours: Jun 26, 2026, 6:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.53
-0.04 (-2.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.56
+0.03 (2.22%)
After-hours: Jun 26, 2026, 6:44 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $93.4M significantly exceed its total debt $15.8M, ensuring strong financial flexibility
Total current assets $100.2M exceed Total current liabilities $40.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$13.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.48 | 6.05 | 10 | |
| Quick ratio | 2.48 | 5.63 | 10 | |
| Debt to Equity | 0.36 | 0.30 | 7.0 | |
| Debt to Assets | 0.14 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 7M | 20M | 18M | 16M |
| Gross Profit | 2M | N/A | 17M | 15M | 12M |
| Operating Income | -69M | -38M | -34M | -50M | -54M |
| Net Income | -68M | -30M | -30M | -48M | -53M |
| EBITDA | -67M | -35M | -31M | -46M | -51M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 0.51 | 8.04 | 4.0 |
| Next quarter | 33.64 | -1.3 | 5.5 |
| Current year | -20.71 | -18.95 | 1.0 |
| Next year | 35.55 | -16.19 | 5.5 |
| Weighted average score | 4.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -56.4 | -50.8 | -59.84 | 17.16 | 3.0 |
| Y/Y | -49.98 | -47.59 | -38.82 | 21.54 | 3.3 |
| 3y average | 88.2 | -0.73 | 11.18 | -68.65 | 4.8 |
| 5y average | 279.93 | -6.46 | 9.68 | -59.09 | 4.5 |
| Weighted average score | 3.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |